Stroke prevention in atrial fibrillation: re-defining ‘real-world data’ within the broader data universe
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Stroke prevention in atrial fibrillation: re-defining ‘real-world data’ within the broader data universe
Authors
Keywords
-
Journal
EUROPEAN HEART JOURNAL
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2018-04-07
DOI
10.1093/eurheartj/ehy236
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Trial watch: Trends in clinical trial design complexity
- (2017) Kenneth A. Getz et al. NATURE REVIEWS DRUG DISCOVERY
- Dabigatran Compared With Rivaroxaban vs Warfarin
- (2017) Amit N. Vora et al. JAMA Internal Medicine
- Major Bleeding Risk During Anticoagulation with Warfarin, Dabigatran, Apixaban, or Rivaroxaban in Patients with Nonvalvular Atrial Fibrillation
- (2017) Gboyega Adeboyeje et al. Journal of Managed Care & Specialty Pharmacy
- Accuracy of Medical Claims for Identifying Cardiovascular and Bleeding Events After Myocardial Infarction
- (2017) Patricia O. Guimarães et al. JAMA Cardiology
- Comparison of performance on Hospital Compare process measures and patient outcomes between hospitals that do and do not participate in Acute Coronary Treatment and Intervention Outcomes Network Registry–Get With The Guidelines
- (2016) Robin Mathews et al. AMERICAN HEART JOURNAL
- Appropriate Use of Antithrombotic Medication in Canadian Patients With Nonvalvular Atrial Fibrillation
- (2016) Alan D. Bell et al. AMERICAN JOURNAL OF CARDIOLOGY
- Evaluation of Dose-Reduced Direct Oral Anticoagulant Therapy
- (2016) Megan E. Barra et al. AMERICAN JOURNAL OF MEDICINE
- Is real world evidence influencing practice? A systematic review of CPRD research in NICE guidances
- (2016) Jessie O. Oyinlola et al. BMC HEALTH SERVICES RESEARCH
- Direct Comparison of Dabigatran, Rivaroxaban, and Apixaban for Effectiveness and Safety in Nonvalvular Atrial Fibrillation
- (2016) Peter A. Noseworthy et al. CHEST
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
- (2016) Paulus Kirchhof et al. EUROPEAN HEART JOURNAL
- New oral anticoagulants: appropriateness of prescribing in real-world setting
- (2016) C. S. Pattullo et al. INTERNAL MEDICINE JOURNAL
- Assessment of Administrative Data to Identify Acute Myocardial Infarction in Electronic Health Records
- (2016) Robert J. Mentz et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Changing Landscape of Randomized Clinical Trials in Cardiovascular Disease
- (2016) W. Schuyler Jones et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF
- (2016) Kevin E. Chan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes
- (2016) Benjamin A. Steinberg et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin
- (2016) Allison Keshishian et al. THROMBOSIS AND HAEMOSTASIS
- Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
- (2016) Torben Bjerregaard Larsen et al. BMJ-British Medical Journal
- Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
- (2016) Torben Bjerregaard Larsen et al. BMJ-British Medical Journal
- Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
- (2016) Xiaoxi Yao et al. Journal of the American Heart Association
- Comparing Non–Vitamin K Oral Anticoagulants
- (2016) Anna L. Parks et al. JAMA Internal Medicine
- Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation
- (2016) David J. Graham et al. JAMA Internal Medicine
- Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Naïve Nonvalvular Atrial Fibrillation
- (2016) Joshua D. Brown et al. Journal of Managed Care & Specialty Pharmacy
- Antithrombotic Treatment Patterns in Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation: The GLORIA-AF Registry, Phase II
- (2015) Menno V. Huisman et al. AMERICAN JOURNAL OF MEDICINE
- Comparison of the Short-Term Risk of Bleeding and Arterial Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients Newly Treated With Dabigatran or Rivaroxaban Versus Vitamin K AntagonistsCLINICAL PERSPECTIVES
- (2015) Géric Maura et al. CIRCULATION
- Adherence to non-vitamin-K-antagonist oral anticoagulant medications based on the Pharmacy Quality Alliance measure
- (2015) Colleen A. McHorney et al. CURRENT MEDICAL RESEARCH AND OPINION
- Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of Cardiology
- (2015) Neville Jackson et al. EUROPEAN HEART JOURNAL
- XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation
- (2015) A. John Camm et al. EUROPEAN HEART JOURNAL
- Comparison of treatment persistence with different oral anticoagulants in patients with atrial fibrillation
- (2015) Tomas Forslund et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Registry-based randomized clinical trials—a new clinical trial paradigm
- (2015) Stefan James et al. Nature Reviews Cardiology
- A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system
- (2015) Janet Schnee et al. THROMBOSIS AND HAEMOSTASIS
- External Validity of the ARISTOTLE Trial in Real-Life Atrial Fibrillation Patients
- (2014) Lovisa Hägg et al. Cardiovascular Therapeutics
- Use of Medicare Data to Identify Coronary Heart Disease Outcomes in the Women's Health Initiative
- (2014) M. A. Hlatky et al.
- Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naive atrial fibrillation patients: Danish nationwide descriptive data 2011-2013
- (2014) J. B. Olesen et al. EUROPACE
- 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
- (2014) Craig T. January et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Clinical Trials Transformation Initiative: innovation through collaboration
- (2014) Pamela Tenaerts et al. NATURE REVIEWS DRUG DISCOVERY
- Thrombus Aspiration during ST-Segment Elevation Myocardial Infarction
- (2013) Ole Fröbert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross-sectional analysis using the General Practice Research Database
- (2012) Sally Lee et al. BMJ Open
- American Industry and the U.S. Cardiovascular Clinical Research Enterprise
- (2011) Robert M. Califf et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Anticoagulant Options — Why the FDA Approved a Higher but Not a Lower Dose of Dabigatran
- (2011) B. Nhi Beasley et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Patient-Centered Outcomes Research Institute — Promoting Better Information, Decisions, and Health
- (2011) A. Eugene Washington et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Linking inpatient clinical registry data to Medicare claims data using indirect identifiers
- (2009) Bradley G. Hammill et al. AMERICAN HEART JOURNAL
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started